- ABBV -0.11%
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
Yahoo Finance · 4 days ago
Open | 164.41 |
High | 163.99 |
Low | 161.89 |
Mkt Cap | 287.04B |
P/E (TTM) | 48.38 |
Div & Yield | 6.20 & 3.81% |
Prev. Close | 162.73 |
52 Wk. Low | 130.96 |
52 Wk. High | 182.89 |
Related stocks
Pharmaceutical company
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 12.31B | 0.70% ▲ |
Net Income | 1.37B | 472.80% ▲ |
Diluted EPS | 2.31 | 496.40% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $3.06 | - |
Q1 2024 | $2.23 | $2.31 |
Q4 2023 | $2.77 | $2.79 |
S&P FuturesES=F | 5,212.50-1.25 (-0.02%) |
Dow FuturesYM=F | 39,014.00-13.00 (-0.03%) |
Nasdaq FuturesNQ=F | 18,194.50-5.00 (-0.03%) |
Reddit, Inc.RDDT | 49.40+2.34% |
Lyft, Inc.LYFT | 16.60-5.25% |
10.25-0.77% |